Baudoin JP

References (3)

Title : GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition - Bestion_2022_Viruses_14_132
Author(s) : Bestion E , Zandi K , Belouzard S , Andreani J , Lepidi H , Novello M , Rouquairol C , Baudoin JP , Rachid M , La Scola B , Mege JL , Dubuisson J , Schinazi RF , Mezouar S , Halfon P
Ref : Viruses , 14 :132 , 2022
Abstract :
PubMedSearch : Bestion_2022_Viruses_14_132
PubMedID: 35062337

Title : GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions - Brun_2022_Autophagy_18_678
Author(s) : Brun S , Bestion E , Raymond E , Bassissi F , Jilkova ZM , Mezouar S , Rachid M , Novello M , Tracz J , Hama A , Lalmanach G , Vanderlynden L , Legouffe R , Stauber J , Schubert T , Plach MG , Courcambeck J , Drouot C , Jacquemot G , Serdjebi C , Roth G , Baudoin JP , Ansaldi C , Decaens T , Halfon P
Ref : Autophagy , 18 :678 , 2022
Abstract :
PubMedSearch : Brun_2022_Autophagy_18_678
PubMedID: 34740311
Gene_locus related to this paper: human-PPT1

Title : GNS561 exhibits potent in vitro antiviral activity against SARS-CoV-2 through autophagy inhibition - Halfon_2020_bioRxiv__
Author(s) : Halfon P , Bestion E , Zandi K , Andreani J , Baudoin JP , La Scola B , Mege JL , Mezouar S , Schinazi RF
Ref : Biorxiv , : , 2020
Abstract :
PubMedSearch : Halfon_2020_bioRxiv__
PubMedID: 33052342